Structure and cancer immunotherapy of the B7 family member B7x

Hyungjun Jeon, Vladimir Vigdorovich, Sarah C. Garrett-Thomson, Murali Janakiram, Udupi A. Ramagopal, Yael M. Abadi, Jun Sik Lee, Lisa Scandiuzzi, Kim C. Ohaegbulam, Jordan M. Chinai, Ruihua Zhao, Yu Yao, Ying Mao, Joseph A. Sparano, Steven C. Almo, Xingxing Zang

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

B7x (B7-H4 or B7S1) is a member of the B7 family that can inhibit T cell function. B7x protein is absent in most normal human tissues and immune cells, but it is overexpressed in human cancers and often correlates with negative clinical outcome. The expression pattern and function of B7x suggest that it may be a potent immunosuppressive pathway in human cancers. Here, we determined the crystal structure of the human B7x immunoglobulin variable (IgV) domain at 1.59 Å resolution and mapped the epitopes recognized by monoclonal antibodies. We developed an in vivo system to screen therapeutic monoclonal antibodies against B7x and found that the clone 1H3 significantly inhibited growth of B7xexpressing tumors in vivo via multiple mechanisms. Furthermore, the surviving mice given 1H3 treatment were resistant to tumor rechallenge. Our data suggest that targeting B7x on tumors is a promising cancer immunotherapy and humanized 1H3 may be efficacious for immunotherapy of human cancers.

Original languageEnglish (US)
Pages (from-to)1089-1098
Number of pages10
JournalCell Reports
Volume9
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Immunotherapy
Tumors
Monoclonal Antibodies
Neoplasms
T-cells
Immunosuppressive Agents
Immunoglobulins
Epitopes
Crystal structure
Tissue
Proteins
Clone Cells
T-Lymphocytes
Therapeutics
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Jeon, H., Vigdorovich, V., Garrett-Thomson, S. C., Janakiram, M., Ramagopal, U. A., Abadi, Y. M., ... Zang, X. (2014). Structure and cancer immunotherapy of the B7 family member B7x. Cell Reports, 9(3), 1089-1098. https://doi.org/10.1016/j.celrep.2014.09.053

Structure and cancer immunotherapy of the B7 family member B7x. / Jeon, Hyungjun; Vigdorovich, Vladimir; Garrett-Thomson, Sarah C.; Janakiram, Murali; Ramagopal, Udupi A.; Abadi, Yael M.; Lee, Jun Sik; Scandiuzzi, Lisa; Ohaegbulam, Kim C.; Chinai, Jordan M.; Zhao, Ruihua; Yao, Yu; Mao, Ying; Sparano, Joseph A.; Almo, Steven C.; Zang, Xingxing.

In: Cell Reports, Vol. 9, No. 3, 2014, p. 1089-1098.

Research output: Contribution to journalArticle

Jeon, H, Vigdorovich, V, Garrett-Thomson, SC, Janakiram, M, Ramagopal, UA, Abadi, YM, Lee, JS, Scandiuzzi, L, Ohaegbulam, KC, Chinai, JM, Zhao, R, Yao, Y, Mao, Y, Sparano, JA, Almo, SC & Zang, X 2014, 'Structure and cancer immunotherapy of the B7 family member B7x', Cell Reports, vol. 9, no. 3, pp. 1089-1098. https://doi.org/10.1016/j.celrep.2014.09.053
Jeon H, Vigdorovich V, Garrett-Thomson SC, Janakiram M, Ramagopal UA, Abadi YM et al. Structure and cancer immunotherapy of the B7 family member B7x. Cell Reports. 2014;9(3):1089-1098. https://doi.org/10.1016/j.celrep.2014.09.053
Jeon, Hyungjun ; Vigdorovich, Vladimir ; Garrett-Thomson, Sarah C. ; Janakiram, Murali ; Ramagopal, Udupi A. ; Abadi, Yael M. ; Lee, Jun Sik ; Scandiuzzi, Lisa ; Ohaegbulam, Kim C. ; Chinai, Jordan M. ; Zhao, Ruihua ; Yao, Yu ; Mao, Ying ; Sparano, Joseph A. ; Almo, Steven C. ; Zang, Xingxing. / Structure and cancer immunotherapy of the B7 family member B7x. In: Cell Reports. 2014 ; Vol. 9, No. 3. pp. 1089-1098.
@article{480d91ea919d462e9cf4e3fa26783232,
title = "Structure and cancer immunotherapy of the B7 family member B7x",
abstract = "B7x (B7-H4 or B7S1) is a member of the B7 family that can inhibit T cell function. B7x protein is absent in most normal human tissues and immune cells, but it is overexpressed in human cancers and often correlates with negative clinical outcome. The expression pattern and function of B7x suggest that it may be a potent immunosuppressive pathway in human cancers. Here, we determined the crystal structure of the human B7x immunoglobulin variable (IgV) domain at 1.59 {\AA} resolution and mapped the epitopes recognized by monoclonal antibodies. We developed an in vivo system to screen therapeutic monoclonal antibodies against B7x and found that the clone 1H3 significantly inhibited growth of B7xexpressing tumors in vivo via multiple mechanisms. Furthermore, the surviving mice given 1H3 treatment were resistant to tumor rechallenge. Our data suggest that targeting B7x on tumors is a promising cancer immunotherapy and humanized 1H3 may be efficacious for immunotherapy of human cancers.",
author = "Hyungjun Jeon and Vladimir Vigdorovich and Garrett-Thomson, {Sarah C.} and Murali Janakiram and Ramagopal, {Udupi A.} and Abadi, {Yael M.} and Lee, {Jun Sik} and Lisa Scandiuzzi and Ohaegbulam, {Kim C.} and Chinai, {Jordan M.} and Ruihua Zhao and Yu Yao and Ying Mao and Sparano, {Joseph A.} and Almo, {Steven C.} and Xingxing Zang",
year = "2014",
doi = "10.1016/j.celrep.2014.09.053",
language = "English (US)",
volume = "9",
pages = "1089--1098",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Structure and cancer immunotherapy of the B7 family member B7x

AU - Jeon, Hyungjun

AU - Vigdorovich, Vladimir

AU - Garrett-Thomson, Sarah C.

AU - Janakiram, Murali

AU - Ramagopal, Udupi A.

AU - Abadi, Yael M.

AU - Lee, Jun Sik

AU - Scandiuzzi, Lisa

AU - Ohaegbulam, Kim C.

AU - Chinai, Jordan M.

AU - Zhao, Ruihua

AU - Yao, Yu

AU - Mao, Ying

AU - Sparano, Joseph A.

AU - Almo, Steven C.

AU - Zang, Xingxing

PY - 2014

Y1 - 2014

N2 - B7x (B7-H4 or B7S1) is a member of the B7 family that can inhibit T cell function. B7x protein is absent in most normal human tissues and immune cells, but it is overexpressed in human cancers and often correlates with negative clinical outcome. The expression pattern and function of B7x suggest that it may be a potent immunosuppressive pathway in human cancers. Here, we determined the crystal structure of the human B7x immunoglobulin variable (IgV) domain at 1.59 Å resolution and mapped the epitopes recognized by monoclonal antibodies. We developed an in vivo system to screen therapeutic monoclonal antibodies against B7x and found that the clone 1H3 significantly inhibited growth of B7xexpressing tumors in vivo via multiple mechanisms. Furthermore, the surviving mice given 1H3 treatment were resistant to tumor rechallenge. Our data suggest that targeting B7x on tumors is a promising cancer immunotherapy and humanized 1H3 may be efficacious for immunotherapy of human cancers.

AB - B7x (B7-H4 or B7S1) is a member of the B7 family that can inhibit T cell function. B7x protein is absent in most normal human tissues and immune cells, but it is overexpressed in human cancers and often correlates with negative clinical outcome. The expression pattern and function of B7x suggest that it may be a potent immunosuppressive pathway in human cancers. Here, we determined the crystal structure of the human B7x immunoglobulin variable (IgV) domain at 1.59 Å resolution and mapped the epitopes recognized by monoclonal antibodies. We developed an in vivo system to screen therapeutic monoclonal antibodies against B7x and found that the clone 1H3 significantly inhibited growth of B7xexpressing tumors in vivo via multiple mechanisms. Furthermore, the surviving mice given 1H3 treatment were resistant to tumor rechallenge. Our data suggest that targeting B7x on tumors is a promising cancer immunotherapy and humanized 1H3 may be efficacious for immunotherapy of human cancers.

UR - http://www.scopus.com/inward/record.url?scp=84919775114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919775114&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2014.09.053

DO - 10.1016/j.celrep.2014.09.053

M3 - Article

C2 - 25437562

AN - SCOPUS:84919775114

VL - 9

SP - 1089

EP - 1098

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 3

ER -